NGM·Healthcare·$1.6B·#297 / 520 in Healthcare
ATAI AtaiBeckley Inc.
39HIGH RISK
CATEGORY BREAKDOWN
GROWTH100
QUALITY0
STABILITY53
VALUATION0
GOVERNANCE20
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+1227.6%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
10 months
30
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
0.9%
99
< 25% strong
Price / Sales
Market cap relative to trailing revenue
381.4x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-1544
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.8%
30
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+83.7%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ATAI WITH…
OR QUICK-COMPARE SECTOR PEERS
RELATED RESEARCH
2 Best Small-Cap Mental Health Tech & Psychedelic Therapeutics Stocks — May 2026May 2, 2026SCORE ALERT
Get notified when ATAI's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.